Get started

Potstocks

$HIPH CEO Confirms Order Delivery to Start Next Week: CBD WaterThe CEO of $HIPH A Expansive High Growth MJ Stock with several acquisitions in the pipe and more to come, has announced that the deliveries for the CBD+Hydro Infused High PH Water will start delivery next week and explained the situation in a tweet earlier today: "Wanted to provide an update, orders will be shipping out next week! Again apologies for delays, migrations issues, etc caused the initial delays, much smoother going forward, 3 weeks for delivery not acceptable. Thanks for everyone's patience! $HIPH" The technicals of the chart also show triangular formations on the hourly going back a month in an upwards direction which confirms the uptrend. Below are some of the major catalysts coming up for the MJ Sector as a whole: Pending US Federal Hemp/CBD legalization DD/research links: (1.) The current Farm Act expires Sept 30th, 2018, legislators will attempt to pass a new Farm Act before the current Act expires, meaning; there's aprox. 99%+ certainty that the proposed US Federal Hemp/CBD legislation will be dealt with by congress in one way or the other on or before Sept 30th, 2018. www.washingtonpost.com The Hemp Farming Act of 2018 contains full spectrum legalization of Hemp & CBD on a US Federal level en.wikipedia.org It is easy to under-estimate the potential economic impact of US Federal Hemp/CBD legalization, but consider; Hemp/CBD has been federally restricted for over 80 years. en.wikipedia.org Not only does CBD derived from Hemp have potential mass use on a national/federal level, but the Hemp by-products of CBD production have approximately 10,000 different additional uses: www.bulkhempwarehouse.com The US Federal legalization of Hemp/CBD is essentially a once-in-a-century event. (2.) On Oct. 17th Canada will experience full Marijuana legalization. This will also be another catalysts and full spectrum legalization of MJ in Canada puts pressure on the US to pass full spectrum legalization of Hemp/CBD for US Farmers to stand a chance of being able to compete with the Canadians in the massive international Hemp/CBD space. (3.) With 2018 being a mid-term election year; Cannabis stocks tend to out-perform when legalization is on the ballot, see the following 2 videos for further explanation: pro.moneymappress.com secure.caseyresearch.com This November 6th these 4 states will vote to legalize Marijuana in different forms: North Dakota: Recreational Marijuana. Michigan: Recreational Marijuana. Utah: Medical Marijuana. Missouri: Medical Marijuana.
OTC:HIPHLong
by StockGuild
Value area under 10.00I am watching the two forces bullish and bearish on this one. As you can see on the daily, we have very defined channel zones. Price is respecting these areas. The pot market is mostly bearish, with decent retracements aka bullish pullbacks (from bearish bias perspective). These are tradeable (I trade them as a counter-trend trade) and typically I see, 1.50 to 2.00 movements. A high probability tradeable pattern has emerged. Currently, I am watching for price to slip back to the 10.00 area of interest. In my opinion; ACB is no longer trading like a speculative market, but now as a supply and demand market. As we appear to have a great deal of supply, suppliers are reporting how they can easily meet supply targets. Prices are set by the government, and supply chains are now emerging. I am expecting/predicting prices to keep slipping until August. The days of 15% moves are gone, but we are seeing consistent days of 3% moves and over 3 or 4 days, that's an easy 9%-12% on a bullish week. I can live with that. I have also noted, that possibly we have some whales shorting this market. The other day I was watching order flow, I noticed some large buying orders in higher price areas, from a bearish perspective, this would be whales taking profit on the big shorts. A tip for risk management; Never trade with capital you cant afford to lose. Once you place a trade, assume it to be gone. If you can't live with that, then you shouldn't be trading with that much capital. Simple enough. This is not financial advice, but purely my opinion and shared thoughts.
TSX:ACBLong
by 4XRandalll
5
Cronos GroupCronos is a great test-case for what happens when a Speculative OTC stock goes to the big time market. They shot up 30% in the days after it went from OTC to the NASDAQ on some HUGE volume. I personally like Cronos a lot. Mike Gorenstein seems like an excellent CEO and they are setting themselves up really nicely in terms of the international picture. HOWEVER. They haven't truly DONE anything yet, at least compared to the other big names in the Canadian cannabis industry. In their most recent financial statement, their Q3FY17 revenue was C$1.3M with a YTD revenue of C$2.5M a SMALL FRACTION of even the less-than-popular MedReleaf who had a Q3FY17 sales of C$11.35M and FY17 of C$31.6M I guess what I am ultimately getting at is that, IMO, Cronos is grossly over valued in terms of Market Cap and I expect that to catch up to them sooner than later if they can't produce financial results on par with the rest of the industry. I can imagine the share price breaking below the lower bounds of the triangle, falling fairly sharply to the Weekly 9EMA and potentially even correcting further. Just my $.02
NASDAQ:CRON
by DPeter85
Crayon sketch of Cannabis Wheaton graphs and forward projectionsIve been invested in the Canadian marijuana sector for just over a year and a half and have had great overall success but most importantly learned A LOT along the way. Weve got a HUGE catalyst coming up in the Canadian Recreational Legalization slated for August 2018 and I for one do not want to be waiting on the sidelines! This is just a VERY rough sketch of what I believe could be very much possible in the coming 6 months before true Canadian recreational legalization. I think that this sort of pattern is potentially VERY possible across the whole sector, but Cannabis Wheaton is an interesting business model that relies heavily on the production of its "subsidiaries." I think that were coming up on another mini-mania where people who've invested in the sector in the past and bailed will be looking to get back in before the next boom. As with all investing, we are relying on people being late, dragging their feet and being indecisive in order to sell the stocks weve purchased earlier to them much higher. As you can see, weve already started to see the Daily 9EMA turn upwards and with a steady stream of good news from many of the holdings of CBW, I don't see us crashing and burning from here. CBW has its fingers in MANY strong LPs and with a Market Cap of ~$550M its upside potential is astronomical. The following assumptions were made: I expect to see approximately 10% increase in the peak of the 9EMA once more between now and the August medium-soft "Green Day." I also expect to see a strong bounce off the 100MA late June, early July before the final run-up. I believe we could then see a solid 30% increase from the peaks of the MA going into the final days of the legalization and then after that, all bets are really off. Things may continue or things may crash back down to the 100MA range. We will have to play that by ear as it come. Feel free to comment about your thoughts. Again, this is a VERY rough estimate of what it COULD look like but based on how the industry as run before, I think its very much in the realm of possiblities. Good luck and HAVE FUN!
OTC:CBWTFLong
by DPeter85
1
VFF Healthy consolidation. No matter how fundamentally strong VFF Is and how solid their execution is , the overall volatility and psychology of the cannabis markets will effect share price. Personally I believe VFF to be very well positioned, in a strong position financially and their operational plans are on track for 2018 and 2019. Short term VFF is in for a tough battle up, overall bulls seem to be exhausted and the bears have been exerting some serious selling pressure both on VFF as an individual stock and the Canadian cannabis market as a whole. From a technical analysis standpoint VFF has immense potential to retrace back to previous highs and maintain them, this would require the bulls to pick up steam. I'm looking for industry wide catalysts and also VFF specific catalysts to move this stock. My time frame for the retracement back to $8.50+ is 2 months
VLong
by navpowarr
MJNA Target 0.50 - 1.00This stock is pretty much looked at as the otc ETF for the marijuana sector. Target based on the sector. The other targets I have mentioned are based on company financials and fundamentals Business Description Medical Marijuana Inc. (OTC Pink Sheets; MJNA) is the first publicly held company vested in the cannabis and industrial hemp space in America. Through its subsidiaries and investment holdings the Company focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol ("CBD") and other products containing CBD-rich hemp oil ("Legal Hemp"). Company products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale in countries that have legalized our hemp oil for the treatment of various illnesses and conditions (such as Brazil and Mexico) and skin care products. The Company is not in the business of selling or dispensing either recreational or medical marijuana, directly or indirectly, so long as marijuana remains a federally controlled substance, however, we are poised and consider ourselves well-positioned for eventual cannabis legalization (the Company's products contain only those substances that are derived from the part of the cannabis plant that is excluded from the definition of marijuana under the Controlled Substances Act and are both federally legal and outside of the purview of the Drug Enforcement Administration). Medical Marijuana, Inc. and Subsidiaries HempMeds® Mexico, HempMeds® Brazil and Kannaway® Announce 2017 as the Largest Revenue Year in Company History PR Newswire SAN DIEGO, Jan. 8, 2018 SAN DIEGO, Jan. 8, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company and its subsidiaries HempMeds® Mexico, HempMeds® Brazil and Kannaway® generated the largest-ever (unaudited) revenue year in its history in 2017, as well as reached major milestones in its business operations. In 2017, Medical Marijuana, Inc. had a number of significant accomplishments, including: Experienced year over year revenue growth of more than 300% compared to 2016 Medical Marijuana, Inc. CEO Dr. Stuart Titus spoke at several national and international cannabis conferences including A4M Mexico, the California Cannabis Business Expo, World Medical Cannabis Conference & Expo, ExpoWeed, the International Fair of Medical Cannabis and the Marijuana Business Conference & Expo Announced the promotion of Vice President of Operations, who also serves as Kannaway CEO, Blake N. Schroeder, Esq., to Chief Operating Officer Appointed Alex Grapov as new International Vice President, Jim Gibson as new Vice President of Operations and Stephen Jones as Chief Marketing Officer Medical Marijuana, Inc. subsidiary Kannaway® was the first direct sales company to offer phyto-cannabinoid botanical products to consumers. A family-oriented company, Kannaway® encourages its brand ambassadors to create their own successful distribution businesses that will positively benefit the wellbeing of the people around them. In 2017, Kannaway® had a number of significant accomplishments including: Launched new products including a Hempy's® line of clothing products, Kannaway® Energy Chews, Kannaway® Essential Oils, updated HempVAP® Terpene-infused Vape, Kannaway® SuperGreens and Kannaway® Pure Gold Announced international expansion with the establishment of Kannaway® Europe Experienced year over year revenue growth of more than 500% compared to 2016 Achieved the largest sales year in its history. HempMeds® Mexico is Medical Marijuana, Inc.'s distribution branch in the country, focusing on providing non-psychoactive cannabidiol (CBD) products to the people of Mexico. HempMeds® Mexico was the first company to have a medical cannabis product approved for import into Mexi
OTC:MJNALong
by StockPicksNYC98
FDA Approval "coming soon"From a post on ihub- an investor emailed investor relations and received this response $$$ to: info@viadermalicensing.com cc: sales@viadermalicensing.com subject: Update mailed-by: gmail.com Hello, I have a few questions: 1-Can we expect a PR with a FDA approval this week or next for your product for treating Premature Ejaculation? 2-Are sales rolling out this quarter for Viabecline? 3-Will the lawsuit be dropped or settled this quarter? Will ViaDerma prevail? 4-Hasn't the efficacy already been done for Viabecline? Why have you started a new independent study in Texas to prove Viabecline's efficacy in treating diabetic foot wounds? 5-How much revenue do you expect from the grass roots THC and non-THC Cannabinoids, both in a patch form, roll on and spray signed with the Canadian company? Are your plans to sell licensing agreements to major producers? Thank you ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ info@viadermalicensing.com 3:08 PM (17 hours ago) FDA approval is on track. No delays are expected. Stand by for updates on that Rollout is also still on time and should be out by the of the quarter (one month from now) We received a continuance to submit our reply to the lawsuit. That's usually pretty standard. We will report developments as they happen but we feel very strongly we will prevail. We cant say too much until after we file our official reply with the court Efficacy has been done but the reason for the independent study is to show we do it better. Can't answer any revenue guidance question yet until we release that to the public. Hopefully soon. Stay tuned for more news in the near future. We expect to report on some of these and other developments shortly. Thanks Investor Relations (310) 734 6111
OTC:VDRMLong
by Cryptocol
VDRM Brings in Ivan Klarich" ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has hired Mr. Ivan Klarich, who is an expert in managing the launching of "Go to Market" strategies for new product compliance. The Company wants to avoid the pitfalls often found in the launching a new product or product line. The Company wants to assure a solid strategy behind the launch for the labeling, marketing and distribution. The "Quality Control" plan will assure the product meets strict guidelines, starting with the manufacturer all the way through to the point of purchase. The Company plans to continue to hire several experts in the specialty pharmaceutical field as the Company rolls out an aggressive growth plan for 2017 and the years ahead." Very excited for this PR and what it means for the long run for VDRM. Anyone who has been following my posts knows I'm very long long on this company in 2017. I think we may see a 20% green day today, but even if we continue to go back down a bit I have no worries and will continuing buying more. VDRM long and strong! Millionaires will be made
OTC:VDRMLong
by Cryptocol
Greatness Takes Time.I'm seeing some bashing of this company on a few other outlets. I think one thing new investors into VDRM need to realize is that greatness takes time. If you bought into it at 0.06-0.07 because somebody told you it was going to run to a $1 overnight, that's all on the trader and not on the stock. If you look at the chart, this is a very healthy company with a very healthy chart. Slow and steady is the way to go. This company is in store for greatness, and I do believe we see $1 in 2017/2018 however new traders need to realize that a jump from pennies to a dollar happens very rarely unless the company undergoes a R/S or has some suspicious activity going on with it. If you are newly invested into VDRM and are currently sitting at a loss or near a loss I encourage you to hold tight and be patient. if you sell without the intent to buy back in, I suggest you ignore this ticker for the next year or so. We will do great things, we have done great things, and great things will continue to happen slowly but surely with this stock. Millionaires will be made.
OTC:VDRMLong
by Cryptocol